Endocyte, Inc. to Present at Upcoming Conferences in September

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WEST LAFAYETTE, Ind., Aug. 27, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced that the company’s management team will present at the following upcoming conferences in September:

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC